Aptamer-Based Delivery of Genes and Drugs Across the Blood–Brain Barrier
Pharmaceuticals · 16.01.2026 · 19 (1) · 164
DOI: 10.3390/ph19010164 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 16.01.2026. Verfasst von Luona Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX 77204, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Cancer Prevention and Research Institute of Texas, National Institute of Health.
Abstract (Originalsprache)
The blood–brain barrier (BBB) restricts therapeutic delivery to the central nervous system (CNS), hindering the treatment of neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, brain cancers, and stroke. Aptamers, short single-stranded DNA or RNA oligonucleotides that can fold into unique 3D shapes and bind to specific target molecules, offer high affinity and specificity, low immunogenicity, and promising BBB penetration via receptor-mediated transcytosis targeting receptors such as the transferrin receptor (TfR) and low-density lipoprotein receptor-related protein 1 (LRP1). This review examines aptamer design through the Systematic Evolution of Ligands by Exponential Enrichment (SELEX) and its variants, mechanisms of BBB crossing, and applications in CNS disorders. Recent advances, including in silico optimization, in vivo SELEX, BBB chip-based MPS-SELEX, and nanoparticle–aptamer hybrids, have identified brain-penetrating aptamers and enhanced the brain delivery efficiency. This review highlights the potential of aptamers to transform CNS-targeted therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX 77204, USA.
ORCID-Profile: Bin Guo
Förderung
- NIH HHS
- Cancer Prevention and Research Institute of Texas
- National Institute of Health
- Cancer Prevention & Research Institute of Texas
Zitieren
APA
Yang, L., Yin, Y., Liu, X., & Guo, B. (2026). Aptamer-Based Delivery of Genes and Drugs Across the Blood–Brain Barrier. Pharmaceuticals, 19(1), 164. https://doi.org/10.3390/ph19010164
Vancouver
Yang L, Yin Y, Liu X, Guo B. Aptamer-Based Delivery of Genes and Drugs Across the Blood–Brain Barrier. Pharmaceuticals. 2026;19(1):164. doi:10.3390/ph19010164
BibTeX
@article{Yang2026,
author = {Yang, Luona and Yin, Yuan and Liu, Xinli and Guo, Bin},
title = {Aptamer-Based Delivery of Genes and Drugs Across the Blood–Brain Barrier},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {1},
pages = {164},
doi = {10.3390/ph19010164}
}
EUVIMED